Search This Blog

Search with Labels

Showing posts with label important. Show all posts
Showing posts with label important. Show all posts

Thursday, May 17, 2012

Karen James, MEBO UK's PR Director publishes article in the Oxford Journals, InnovAiT




It is with great pride that I announce one of the greatest achievements MEBO UK’s Public Relations Director, Karen James, has accomplished to date - to be published in the Oxford Journals of the Oxford University Press, InnovAiT.


Full Text:
http://rcgp-innovait.oxfordjournals.org/cgi/content/full/ins093?ijkey=bF4nglzYtAz4Cbf&keytype=ref

PDF:
http://rcgp-innovait.oxfordjournals.org/cgi/reprint/ins093?
ijkey=bF4nglzYtAz4Cbf&keytype=ref


My body produces an offensively pungent chemical
Karen James
InnovAiT 2012; doi: 10.1093/innovait/ins093

It was only one year ago, on March 28, 2011, that Karen spearheaded the International Raising Awareness Campaign in the UK medical system calling sufferers from around the world to write testimonials for her to submit to the UK Medical Research Council, the General Medical Council, British Medical Association, Royal College Physicians, and more. Our whole community is very grateful to the many sufferers who participated in this campaign. As a result of this very diligent determination on her part, Karen has accomplished, in only a years’ time, not only to work with UK DUETs, NHS Evidence, National Institute for Health and Clinical Excellence, to publish 10 body odor related uncertainties / questions, now found in the Library of NHS UK database, about the effects of treatment for TMAU, but now she has her own article published in InnovAiT.

This is a perfect example of how a sufferer standing up and taking action can bring about significant change. Imagine what it would be like if each sufferer stood up and took action in his or her own way! We would be well on our way toward finding a cure if this were the case.

An excerpt from this article:

The GP perspective
It is challenging when faced with a patient that you do not know how to
help. The curriculum is vast and reflects the level of knowledge GPs have to acquire, and maintain, over their careers. It is inevitable that you will experience patients from time to time with problems that will stretch your knowledge to its limits. As Karen has alluded to throughout this article, it is important to listen to patient concerns, be open-minded, and be prepared to look things up and/or take advice from both primary care and specialist colleagues if you feel that you are treading on uncertain ground.




A WORD FROM KAREN:

We should never allow ourselves to be dragged down by the scepticism of fellow sufferers regarding ‘raising awareness’ campaigns; thanks to the UK raising awareness campaigns last year, synchronised e-mailing to the Royal College of General Practitioners and follow-up letters and calls, I managed to publish an ‘odour article’ in ‘Innovait’, which is a journal for graduating doctors published by the RCGP.

We all know that unsolicited manuscripts are most often rejected. I was lucky because somebody at RCGP forwarded one of my raising awareness e-mails to the Innovait editors, perhaps with a suggestion that they feature TMAU in an edition of the journal. Without this initial recommendation I think my article would not have been published so it is thanks to all those people who joined me in sending e-mails to the UK medical establishments and thanks to all those people who allowed me to use their true accounts of ‘living with odour’ for the raising awareness campaigns. Also, the sharing of information during the meet-ups was also very helpful so thanks to those who organise the meet-ups and those who attend them. Several months later, we have a small (but significant) result.

The original article had been written for (and already rejected by) newspapers so it was not suitable for a medical journal. However, the editors were incredibly supportive and helped me with the lengthy process of editing, re-editing, rearranging the content of the article so that all emotive adjectives were removed, the underlying critical tone of the medical profession was diminished and a scientific diagram, courtesy of Dr Elizabeth Shephard, was included.

Odour conditions are covered by the UK Disability Act in that you can be classified ‘disabled’ for conditions which adversely affect your day-to day activities.
Although 800 words were cut, I hoped the main points would still be included: the lack of understanding of most GPs and failure to diagnose; the danger of GP’s denying the problem; the need for research into odour conditions; the need for sensitivity and mental health support for younger sufferers particularly; the expense of nutritional supplements for sufferers who are unemployed or under-employed because of the condition.

E-mail discussions with the team of RCGP’s Innovait GPs were very interesting and confirmed:

IF YOU ARE UNEMPLOYED BECAUSE OF YOUR ODOUR CONDITION
Odour conditions are covered by the UK Disability Act in that you can be classified ‘disabled’ for conditions which adversely affect your day-to day activities. It follows that unemployed sufferers in the UK should be entitled to disability benefits.

IF YOU CANNOT AFFORD SUPPLEMENTS AND PROBIOTICS
The GPs questioned the validity of my statement that TMAU sufferers find it hard to get supplements on prescription. They clarified that any GP is able to prescribe calcium supplements etc. (obviously, it can be cheaper to buy certain supplements at the pharmacy if you are employed) and that consultants have the greater power of being able to prescribe virtually anything they consider relevant to the patient’s wellbeing.


CALL TO ACTION:

Imagine what it would be like if each sufferer stood up and took action in his or her own way!
Each sufferer who has not yet been tested for TMAU is invited to print Karen's InnovAiT article and Dr. Shephard's NIH articles on Differential Diagnosis of TMAU, in which the diagnosis of Transient TMAU (intermittent odor) is introduced, noting its very reputable source, and take it to your respective GP to ask him/her to prescribe the TMAU Test. By doing so, not only will you get your test, but you will also carry on the torch of the Raising Awareness Campaign. Even if your doctor tells you that he/she does not detect your odor, Drs. Shephard and Phillips’ article clearly states that it could be transient (intermittent odor – not always present).

In an effort to show strength in unity of sufferers in the UK, this article makes mention of the three primary sufferer support forums/websites that this blog links to on the menubar Community tab, the new UK TMAU Website, Arun's breath and body odour forum, and MEBO's website. On behalf of our international community, we take our hats off to you Karen, for tapping into the medical community on our behalf. We also would like to express our heartfelt gratitude to Dr. Elizabeth Shephard for her contribution to this article and for all she has done for our community. THANK YOU!

María


María de la Torre
Founder and Executive Director

A Public Charity
www.meboresearch.org
www.brasil.meboresearch.org
maria.delatorre@meboresearch.org
MEBO's Blog (English)
El Blog de MEBO (español)
MEBO Brasil - Blog (Portuguese)



SUPPORT THE MEBO MISSION: Click Amazon button at right sidebar of this blog when shopping online for the holidays
at no extra cost to you.
MEBO gets small commission from Amazon.


Please use your credit card to make your donation to MEBO.


Subscribe for latest posts : Enter your email address:

Delivered by FeedBurner


A EURORDIS and NORD Member Organization

Wednesday, February 29, 2012

Take action to Raise Awareness today, Rare Disease Day!

Please click on this link
See examples below of emails written today.
Please feel free to copy and paste excerpts to create your own.


TODAY IS THE DAY TO TAKE ACTION
AS A UNITED COMMUNITY!

As mentioned in previous posts, our international community at MEBO Research and all sufferers from around the world have been "called to arms" to prepare to join the National Organization for Rare Disorders (NORD) and Eurordis in important advocacy initiatives organized for the Rare Disease Day, today, February 29, 2012. MEBO urges sufferers to take a moment to participate in the two mass email/mail campaigns aimed at the authorities in the US and UK that could be most influential in assisting us in our quest to initiate research and find a cure.

**You may include a link to the TMAU paper written by Dr. Elizabeth Shephard for MEBO Research, http://www.meboresearch.org/Trimethylaminuria%20Paper%20by%20Dr.%20Elizabeth%20Shephard.pdf **

CONTACT YOUR GOVERNMENT OFFICIALS IN THE UNITED STATES:
"In solidarity with EURORDIS and NORD""

By following the easy steps in this virtual tool, you can let your elected officials know that rare diseases are important to you! NORD has provided a sample letter for you, ready-to-go, though we certainly encourage you to take an extra moment to personalize your message and make it resonate.

Once you complete this action alert, your message will be instantly and electronically sent, though you have the option to print and mail your message if you prefer. You may choose to send your message to:
- The President and Vice President of the United States
- The two Senators who represent you in the US Senate
- The Congressperson who represents you in the US House of Representatives
- Your State's Governor and Lt. Governor
- Your representatives in your state's legislature


CONTACT YOUR GOVERNMENT OFFICIALS IN THE UNITED KINGDOM:
This is an example of the email you can send. You can either copy and paste it, or modify it to say whatever else you may want to say:

"In solidarity with EURORDIS and NORD"

TMAU and other foul-odour-producing metabolic/systemic disorders (which, unfortunately, are still un-named) are very highly under-diagnosed conditions. TMAU (and other odour disorders) are considered rare disorders. However, the fact that they are so rarely diagnosed is a key issue. We have contacted you before requesting help with a simple task – raising awareness of TMAU and odour conditions primarily amongst the medical professions. We ask you now, on this day which recognises rare diseases, to reconsider the plight of sufferers of this devastating, invisible disability. If our existence continues to be ignored, research is less likely to occur and a cure will not be found. It is our right to be heard on this day and to protest against the social rejection and dismissive attitudes we face.

Below is a raising awareness petition devised by MEBO Research which can be signed (anonymously) by any individuals who believe that sufferers of odour disorders have the same human rights as other human beings.

http://www.meboblog.com/2011/06/raising-awareness-and-research-funding.html

UK Contacts


Royal College General Practitioners
circ@rcgp.org.uk
chair-circ@rcgp.org.uk
chiefexecutive@rcgp.org.uk
president@rcgp.org.uk
chairman@rcgp.org.uk
vicechair@rcgp.org.uk
chair-scottish-counc@rcgp.org.uk
nedmunds@rcgp.org.uk
chairmanni@rgcp.org.uk
international@rcgp.org.uk
ppgchair@rcgp.org.uk
NSparrow@rcgp.org.uk
rpalmer@rcgp.org.uk
doliver@rcgp.org.uk
pnewman@rcgp.org.uk
swest@rcgp.org.uk

Royal college of Physicians
Humphrey.Hodgson@RCPLondon.ac.uk
education-courses@rcplondon.ac.uk

General Medical Council
education@gmc-uk.org
gmc@gmc-uk.org
publicatons@gmc-uk.org
gmctoday@gmc-uk.org

Media
thismorning@itv.com


Medical Research Council
Linda.Willmott@headoffice.mrc.ac.uk.

NPSA
enquiries@npsa.nhs.uk
queries@nres.npsa.nhs.uk


Health MPs
lansleya@parliament.uk
simon.burns.mp@parliament.uk
dhmail@dh.qsi.gov.uk
anne.milton.mp@parliament.uk

Dental Orgs.
enquiries@bda.org
dentalbranch@dhsspsni.gov.uk
wag-en@mailuk.custhelp.com
fgdp@rcseng.ac.uk
editor@badn.org.uk

USA Infectious Diseases Division Office, Northwestern University
gnoskin@northwestern.edu
Gary A. Noskin, MD Professor, Medicine, Infectious Disease Division at Northwestern University.


Friday, December 9, 2011

Disability Benefits Presentation at MEBO’S Washington DC 2011 Meetup

With the economic recession and high unemployment rate, many sufferers have experienced difficulty finding and keeping jobs. This economic state only aggravates the employment challenges customarily encountered by sufferers during good economic times. Consequently, many have fallen into a serious state of depression and anxiety, and a quite a few have emailed Cheryl Fields, MEBO's Community Outreach Director and me asking for information about the application process for Social Security benefits in the United States.

In light of these difficult times that so many sufferers are going through, and to address the questions about the qualifications for these disability benefits, I would like to present the,

BannerFans.com
that she did on a conference call that came into our Washington DC Meetup this year, since she was unable to physically attend due to last minute problems with her flight. I think this presentation should answer many questions sufferers may have at this time.

PLEASE NOTE THAT THIS INFORMATION APPLIES ONLY FOR
SOCIAL SECURITY DISABILITY BENEFITS
OF THE U.S. SOCIAL SECURITY ADMINISTRATION

Cheryl, also known on the forums as "Dr. StillStanding," is a TMAU sufferer herself who fought through all the obstacles this condition brings to earn a Bachelor Degree in General Business, a Master's Degree in Business Administration (MBA), and is a Doctoral Candidate (PH.D./ABD) in Human Resources Management, from the School of Business. Her achievements are great by any standards, and especially so as a body odor sufferer who has had to fight through many the many challenges this condition brings along the way.

Even though Cheryl is always available to speak to any sufferer who needs to tap into her knowledge, please keep in mind that Cheryl is recovering from surgery she had just prior to Thanksgiving. Hopefully, the transcript of her presentation will answer your questions. I'm certain that everyone will join me in wishing Cheryl a speedy recovery.

María


María de la Torre
Founder and Executive Director

A Public Charity
www.meboresearch.org
www.brasil.meboresearch.org
maria.delatorre@meboresearch.org
MEBO's Blog (English)
El Blog de MEBO (español)
MEBO Brasil - Blog (Portuguese)



SUPPORT THE MEBO MISSION: Click Amazon button at right sidebar of this blog when shopping online for the holidays
at no extra cost to you.
MEBO gets small commission from Amazon.


Please use your credit card to make your donation to MEBO.


Subscribe for latest posts : Enter your email address:

Delivered by FeedBurner


A EURORDIS and NORD Member Organization

Wednesday, November 2, 2011

TEN Body Odor Questions on "Nutritional metabolic and endocrine disorders > TMAU" published in UK NHS Database


BREAKING NEWS : On October 21, 2011, ten (10) body odor related uncertainties / questions have been published in the October report to the UK National Institutes for Health Research (NIHR) Database, under the category of ‘Nutritional metabolic and endocrine disorders > Trimethylaminuria’(see left column).
The benefit of the publication of these questions...is that they have been identified and made explicit by the authorities in an attempt to address and “prioritise new research” of the questions/uncertainties published.
These questions can be seen in the Library of NHS UK, Database of Uncertainties about the Effects of Treatments (UK DUETs).
Six (6) of these listed uncertainties have referenced their source to MEBO Research (see, "View Details of each question"), and four (4) of them reference the source to the DUETs Editorial Team.
The benefit of this publication by the Special Health Authority established by order of the Secretary of State for Health, is that these questions have been identified and made explicit by the authorities in an attempt to address and “prioritise new research” of the questions/uncertainties published. With this validation, it is hoped that research grants would be more readily obtained from government and private sources to study these uncertainties.


The following questions are the nine (9) uncertainties 'From patients' and one (1) 'From professionals' published in this NHS Evidence website of the National Institute for Health and Clinical Excellence (NICE).

From Professionals: (Click on 'View Details') Is there a bacteria responsible for producing trimethylamine (TMA) in the gut?

From Patients: (Click on 'View Details' of each question)
  1. Do high plasma levels of trimethylamine (TMAO) gut flora metabolism of phosphatidylcholine cause cardiovascular disease?
  2. In-vitro screening to test whether ataluren (PTC124) can correct functional consequences of premature termination mutations of the Flavin containing monooxygenase 3 (FMO3) gene?
  3. To what extent are individuals with trimethylaminuria, and lack functional hepatic flavin containing monooxygenase 3 (FMO3) substrates, unable to oxidize other odiferous FMO3-specific substrates and does this contribute significantly to body odour?
  4. Which bacterial species in the human intestine are responsible for the generation of trimethylamine?
  5. Would a comprehensive biochemical screening test for trimethylaminuria help patients?
  6. Do probiotics significantly reduce trimethylaminuria (TMAU1) producing bacteria in the human intestine and does this result in clinically relevant decreases in TMA production, and thus body odour, in patients with TMAU1?
  7. Enzyme replacement therapy for trimethylaminuria (odour problems)
  8. How effective are antibiotics for trimethylaminuria?
  9. How effective is a choline elimination diet for treating trimethylaminuria?


HOW DID THIS COME ABOUT? On March 2011, our very own, Karen James, launched a campaign, and using her own words in a post she wrote for this blog, “…to contact the main British medical organisations and health politicians and appeal to their humanity through persuasive letters, e-mails, and follow-up phone calls.” Sufferers from not only the UK, but from other countries, joined in and sent their emails/mails on targeted dates set up by Karen to present testimonials to these authorities. Eventually, Karen put me in contact with Mark Fenton, UK Database of Uncertainties about the Effects of Treatments (UK DUETs), Project Manager, NHS Evidence, National Institute for Health and Clinical Excellence.

By July 2011, Karen was already raising awareness on a high-profile TV show in an 8-minute interview, as the wheels in the British General Medical Council (GMC) and other agencies were turning; and eventually, she was referred to Mark Fenton, Project Manager of UK DUETs. She and I began to work with Mark with the help of an expert in FMO3 in the UK to create a list of questions or uncertainties to be published in the UK National Institute for Health and Clinical Excellence (NICE), DUETs. Researchers are welcome to make reference to these question if they wish to apply for government or private research grants to them.

Our most sincere gratitude goes to Karen James for having initiated and followed through on this endeavor. Without her taking these measures, this would never have come to fruition. This is a perfect example of how one person can make a difference.



HISTORY OF SUFFERERS’ EFFORTS TO RAISE AWARENESS:

Since as far back as the early to mid 1990s, when a woman told her story in a British documentary about her bromhidrosis and hyperhidrosis, and in 1999, when Alice Mata wrote her book, When Bathing is Not Enough, sufferers have attempted bear testimonials to tell the world of the tribulations a sufferer of body odor encounters on a daily basis in hopes of raising awareness and thus initiating change. Other sufferers have told their stories in books such as, Shattered, The Foul Body Odor that Almost Killed Me, and an Anthology, OUR JOURNEY: OVERCOMING THE STIGMA OF THE INVISIBLE MONSTER, and in televised programs and YouTube videos, such as those referenced in this blog under keyword, Testimonial/Evidence.

Other aspects of our international community’s efforts to raise awareness involves email/mail campaigns to targeted government agencies and the medical community. These projects have included the Raising Awareness in the Mental Health Community regarding the Olfactory Reference Syndrome (ORS) diagnosis, and MEBO's Technical Consultant designing flyers to be printed by sufferers throughout the world and left at strategic places, like libraries, schools, doctor’s office, hospitals, etc. Each and every sufferer is encouraged to attempt to communicate with his or her physician by providing the physician with published literature on body odor conditions. These are only some ways to raise awareness of Body Odor Conditions in the medical community, and sufferers are encouraged to "think outside the box" to come up with many more.


María de la Torre
Founder and Executive Director

A Public Charity
www.meboresearch.org
www.brasil.meboresearch.org
maria.delatorre@meboresearch.org
MEBO's Blog (English)
El Blog de MEBO (español)
MEBO Brasil - Blog (Portuguese)



SUPPORT THE MEBO MISSION: Click Amazon button at right sidebar of this blog when shopping online for the holidays
at no extra cost to you.
MEBO gets small commission from Amazon.


Please use your credit card to make your donation to MEBO.


Subscribe for latest posts : Enter your email address:

Delivered by FeedBurner


A EURORDIS and NORD Member Organization